+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Gene Synthesis (Research Use) Market Size, Share & Trends Analysis Report By Method (Solid-phase Synthesis, Chip-based Synthesis), By Service, By Application, By End-use, By Research Phase, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 122 Pages
  • August 2023
  • Region: Europe
  • Grand View Research
  • ID: 5876219
Description Jump to:
The Europe gene synthesis (research use) market size is expected to reach USD 998.9 million by 2030, growing at 15.8% CAGR from 2023 to 2030. The growth is mainly driven by various factors including favorable government policies and the development of enzymatic DNA synthetic process. Moreover, decreasing prices of DNA sequencing and synthesis support the market growth.

Gene synthesis is utilized in vaccine development to respond quickly against emerging infections. In addition, gene synthesis has an important role in developing viral vectors used as a delivery system in vaccine development. Viral vectors can deliver antigen genes into host cells, stimulating the immune system against pathogens. Thus, the significance of gene synthesis in vaccine development is projected to drive market growth during the forecast period.

The market has grown substantially over the last few years, owing to the decreasing prices of DNA synthesis and sequencing due to technological advances in human genome sequencing. Moreover, gene synthesis has unique capabilities to make physical copies of genes accurately, easily, and efficiently. The cost of gene synthesis per base pair has decreased drastically from about USD 10 to USD 0.10 over the past decade.

Furthermore, the favorable government policies regarding synthetic biology and several strategic initiatives undertaken by key players drive market growth. For instance, the UK Research Council established The Synthetic Biology for Growth program. The program was focused on research and investment in synthetic biology. The original duration of the program was from 2014 to 2020; however, due to the market's attractiveness, the program investments were extended till 2022.

Major players operating in the market are developing advanced technologies, launching innovative solutions, and partnering with others to gain a competitive advantage. For instance, in May 2023, Twist Bioscience announced the launch of a portfolio of RNA sequencing tools to accelerate biomarker discovery and precision medicine research. Such efforts by key players and the government are expected to fuel the market demand in the coming years.

Europe Gene Synthesis (Research Use) Market Report Highlights

  • By method, the solid phase synthesis segment accounted for the largest share in 2022. The segment is witnessing growth due to growing demand from various sectors, including pharmaceuticals, drug development, agriculture, and research
  • By services, the antibody DNA synthesis segment accounted for the largest share in 2022. The dominance of the segment is attributable to the advancements in the field of recombinant antibody technology
  • By application, the gene & cell therapy development segment dominated the market in 2022 and is expected to showcase the fastest CAGR over the forecast period. This growth mainly results from the rising use of gene synthesis methods for cloning synthetic therapeutic genes
  • By the research phase, the clinical phase held the largest revenue share in 2022, and it is expected to witness the fastest CAGR over the forecast period. The rising number of clinical trials primarily drives this growth
  • By end-use, the academic & government research institutions segment accounted for the largest share in 2022. The partnerships and strategic alliances between various companies and research institutes have also helped boost segment growth.
  • France held the largest revenue share in 2022 in Europe, mainly due to the efforts of market participants to maintain their position and increase investment in industry in the country
  • The Netherlands is expected to grow at the highest CAGR from 2023 to 2030. This is due to the presence of biotechnology companies and favorable government policies in the country


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Market definitions
1.2. Information Procurement
1.2.1. Market formulation & data visualization
1.2.2. Data validation & publishing
1.3. Research Assumptions
1.4. Research Methodology
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.1.1. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. Global Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Rising investment in the synthetic biology market
3.3.1.2. Advent of enzymatic DNA synthesis process
3.3.1.3. Technological advancements in the DNA synthesis platforms
3.3.1.4. Declining price of DNA synthesis & sequencing
3.3.2. Market Restraint Analysis
3.3.2.1. Lack of skilled professionals
3.3.2.2. Misuse of gene synthesis
3.4. Industry Analysis Tools
3.4.1. Porter’s Five Forces Analysis
3.4.2. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
3.4.3. COVID-19 Impact Analysis
Chapter 4. Europe Gene Synthesis (Research Use) Market: Method Estimates & Trend Analysis
4.1. Method Movement Analysis & Market Share, 2022 & 2030
4.2. Europe Gene Synthesis (Research Use) Market Estimates & Forecast, By Method (USD Million)
4.3. Solid-Phase Synthesis
4.3.1. Solid Phase Synthesis Market, 2018 - 2030 (USD Million)
4.4. Chip Based Synthesis
4.4.1. Chip-Based Synthesis Market, 2018 - 2030 (USD Million)
4.5. PCR-based Enzyme Synthesis
4.5.1. PCR-based based Enzyme Synthesis Market, 2018 - 2030 (USD Million)
Chapter 5. Europe Gene Synthesis (Research Use) Market: Service Estimates & Trend Analysis
5.1. Service Movement Analysis & Market Share, 2022 & 2030
5.2. Europe Gene Synthesis (Research Use) Market Estimates & Forecast, By Service (USD Million)
5.3. Antibody DNA Synthesis
5.3.1. Antibody DNA Synthesis Market, 2018 - 2030 (USD Million)
5.4. Viral DNA Synthesis
5.4.1. Viral DNA Synthesis Market, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Europe Gene Synthesis (Research Use) Market: Application Estimates & Trend Analysis
6.1. Application Movement Analysis & Market Share, 2022 & 2030
6.2. Europe Gene Synthesis (Research Use) Market Estimates & Forecast, By Application (USD Million)
6.3. Gene & Cell Therapy Development
6.3.1. Gene & Cell Therapy Development Market, 2018 - 2030 (USD Million)
6.4. Vaccine Development
6.4.1. Vaccine Development Market, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Europe Gene Synthesis (Research Use) Market: Research Phase Estimates & Trend Analysis
7.1. Research Phase Movement Analysis & Market Share, 2022 & 2030
7.2. Europe Gene Synthesis (Research Use) Market Estimates & Forecast, By Research Phase (USD Million)
7.3. Preclinical
7.3.1. Preclinical Market, 2018 - 2030 (USD Million)
7.4. Clinical
7.4.1. Clinical Market, 2018 - 2030 (USD Million)
Chapter 8. Europe Gene Synthesis (Research Use) Market: End-use Estimates & Trend Analysis
8.1. End-use Movement Analysis & Market Share, 2022 & 2030
8.2. Europe Gene Synthesis (Research Use) Market Estimates & Forecast, By End-use (USD Million)
8.3. Biopharmaceutical & Pharmaceutical Companies
8.3.1. Biopharmaceutical & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
8.4. Academic & Government Research Institutes
8.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
8.5. Contract Research Organizations
8.5.1. Contract Research Organizations Market, 2018 - 2030 (USD Million)
Chapter 9. Europe Gene Synthesis (Research Use) Market: Region Estimates & Trend Analysis
9.1. Europe Gene Synthesis (Research Use) Market: Region Outlook
9.2. Europe
9.2.1. Europe Gene Synthesis Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.2.2. Germany
9.2.2.1. Key Country Dynamics
9.2.2.2. Target Disease Prevalence
9.2.2.3. Competitive Scenario
9.2.2.4. Germany gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.2.3. France
9.2.3.1. Key Country Dynamics
9.2.3.2. Target Disease Prevalence
9.2.3.3. Competitive Scenario
9.2.3.4. France gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.2.4. UK
9.2.4.1. Key Country Dynamics
9.2.4.2. Target Disease Prevalence
9.2.4.3. Competitive Scenario
9.2.4.4. UK gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.2.5. Italy
9.2.5.1. Key Country Dynamics
9.2.5.2. Target Disease Prevalence
9.2.5.3. Competitive Scenario
9.2.5.4. Italy gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.2.6. Spain
9.2.6.1. Key Country Dynamics
9.2.6.2. Target Disease Prevalence
9.2.6.3. Competitive Scenario
9.2.6.4. Spain gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.2.7. Denmark
9.2.7.1. Key Country Dynamics
9.2.7.2. Target Disease Prevalence
9.2.7.3. Competitive Scenario
9.2.7.4. Denmark gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.2.8. Sweden
9.2.8.1. Key Country Dynamics
9.2.8.2. Target Disease Prevalence
9.2.8.3. Competitive Scenario
9.2.8.4. Sweden gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.2.9. Norway
9.2.9.1. Key Country Dynamics
9.2.9.2. Target Disease Prevalence
9.2.9.3. Competitive Scenario
9.2.9.4. Norway gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.2.10. Netherland
9.2.10.1. Key Country Dynamics
9.2.10.2. Target Disease Prevalence
9.2.10.3. Competitive Scenario
9.2.10.4. Netherland gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.2.11. Switzerland
9.2.11.1. Key Country Dynamics
9.2.11.2. Target Disease Prevalence
9.2.11.3. Competitive Scenario
9.2.11.4. Switzerland gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Share Analysis, 2022
10.4. Company Profiles/Listing
10.4.1. GenScript
10.4.1.1. Overview
10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.1.3. Method Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. Azenta, Inc. (GENEWIZ)
10.4.2.1. Overview
10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.2.3. Method Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. Boster Biological Technology
10.4.3.1. Overview
10.4.3.2. Method Benchmarking
10.4.3.3. Strategic Initiatives
10.4.4. Twist Bioscience
10.4.4.1. Overview
10.4.4.2. Method Benchmarking
10.4.4.3. Strategic Initiatives
10.4.5. ProteoGenix, Inc
10.4.5.1. Overview
10.4.5.2. Method Benchmarking
10.4.5.3. Strategic Initiatives
10.4.6. Biomatik.
10.4.6.1. Overview
10.4.6.2. Method Benchmarking
10.4.6.3. Strategic Initiatives
10.4.7. ProMab Biotechnologies, Inc.
10.4.7.1. Overview
10.4.7.2. Method Benchmarking
10.4.7.3. Strategic Initiatives
10.4.8. Thermo Fisher Scientific, Inc
10.4.8.1. Overview
10.4.8.2. Method Benchmarking
10.4.8.3. Strategic Initiatives
10.4.9. Integrated DNA Technologies, Inc. (Danaher)
10.4.9.1. Overview
10.4.9.2. Method Benchmarking
10.4.9.3. Strategic Initiatives
10.4.10. OriGene Technologies, Inc.
10.4.10.1. Overview
10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.10.3. Method Benchmarking
10.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Europe gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 4 Europe gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 5 Europe gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 6 Europe gene synthesis (research-use) market by Research Phase, 2018 - 2030 (USD Million)
Table 7 Europe gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 8 UK gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 9 UK gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 10 UK gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 11 UK gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 12 UK gene synthesis (research-use) market by Research Phase, 2018 - 2030 (USD Million)
Table 13 Germany gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 14 Germany gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 15 Germany gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 16 Germany gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 17 Germany gene synthesis (research-use) market by Research Phase, 2018 - 2030 (USD Million)
Table 18 France gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 19 France gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 20 France gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 21 France gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 22 France gene synthesis (research-use) market by Research Phase2018 - 2030 (USD Million)
Table 23 Italy gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 24 Italy gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 25 Italy gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 26 Italy gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 27 Italy gene synthesis (research-use) market by Research Phase, 2018 - 2030 (USD Million)
Table 28 Spain gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 29 Spain gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 30 Spain gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 31 Spain gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 32 Spain gene synthesis (research-use) market by Research Phase, 2018 - 2030 (USD Million)
Table 33 Denmark gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 34 Denmark gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 35 Denmark gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 36 Denmark gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 37 Denmark gene synthesis (research-use) market by Research Phase, 2018 - 2030 (USD Million)
Table 38 Sweden gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 39 Sweden gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 40 Sweden gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 41 Sweden gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 42 Sweden gene synthesis (research-use) market by Research Phase, 2018 - 2030 (USD Million)
Table 43 Norway gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 44 Norway gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 45 Norway gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 46 Norway gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 47 Norway gene synthesis (research-use) market by Research Phase, 2018 - 2030 (USD Million)
Table 48 Netherland gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 49 Netherland gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 50 Netherland gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 51 Netherland gene synthesis (research-use) market by Research Phase, 2018 - 2030 (USD Million)
Table 52 Netherland gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 53 Switzerland gene synthesis (research-use) market by End-use, 2018 - 2030 (USD Million)
Table 54 Switzerland gene synthesis (research-use) market by Method, 2018 - 2030 (USD Million)
Table 55 Switzerland gene synthesis (research-use) market by Services, 2018 - 2030 (USD Million)
Table 56 Switzerland gene synthesis (research-use) market by Application, 2018 - 2030 (USD Million)
Table 57 Switzerland gene synthesis (research-use) market by Research Use, 2018 - 2030 (USD Million)
Table 58 Participant’s overview
Table 59 Financial performance
Table 60 Key companies undergoing expansions
Table 61 Key companies undergoing acquisitions
Table 62 Key companies undergoing collaborations
Table 63 Key companies launching new products/services
Table 64 Key companies undergoing partnerships
Table 65 Key companies undertaking other strategies
List of Figures
Fig. 1 Europe gene synthesis (research-use) market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modeling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market snapshot
Fig. 13 Segment snapshot
Fig. 14 Segment snapshot
Fig. 15 Segment snapshot
Fig. 16 Competitive landscape snapshot
Fig. 17 Market trends & outlook
Fig. 18 Porter’s five force analysis
Fig. 19 SWOT analysis, by factor (Political, Economic, Social, Technological, and Legal )
Fig. 20 Europe gene synthesis (research use) market: method outlook key takeaways
Fig. 21 Europe gene synthesis (research use) market: method movement analysis
Fig. 22 Solid-phase synthesis market, 2018 - 2030 (USD Million)
Fig. 23 Chip-based synthesis market, 2018 - 2030 (USD Million)
Fig. 24 PCR-based enzyme synthesis market, 2018 - 2030 (USD Million)
Fig. 25 Europe gene synthesis (research use) market: services outlook and key takeaways
Fig. 26 Europe gene synthesis (research use) market: services movement analysis
Fig. 27 Antibody DNA synthesis market, 2018 - 2030 (USD Million)
Fig. 28 Viral DNA synthesis market, 2018 - 2030 (USD Million)
Fig. 29 Others market, 2018 - 2030 (USD Million)
Fig. 30 Europe gene synthesis (research use) market: application outlook and key takeaways
Fig. 31 Europe gene synthesis (research use) market: application movement analysis
Fig. 32 Gene & cell therapy development market, 2018 - 2030 (USD Million)
Fig. 33 Vaccine development market, 2018 - 2030 (USD Million)
Fig. 34 Others market, 2018 - 2030 (USD Million)
Fig. 35 Europe gene synthesis (research use) market: End-use outlook key takeaways
Fig. 36 Europe gene synthesis (research use) market: end-use movement analysis
Fig. 37 Biotechnology and pharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 38 Academic and government research institutes market, 2018 - 2030 (USD Million)
Fig. 39 Contract research organizations market, 2018 - 2030 (USD Million)
Fig. 40 Europe gene synthesis (research use) market: research phase outlook and key takeaways
Fig. 41 Europe gene synthesis (research use) market: research phase movement analysis
Fig. 42 Preclinical market, 2018 - 2030 (USD Million)
Fig. 43 Clinical market, 2018 - 2030 (USD Million)
Fig. 44 Regional marketplace: Key takeaways
Fig. 45 Regional marketplace: Key takeaways
Fig. 46 Europe gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 UK gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Cancer incidence, 2022
Fig. 50 Key country dynamics
Fig. 51 Germany gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Cancer incidence, 2018-2030
Fig. 53 Key country dynamics
Fig. 54 France gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Cancer incidence 2018-2030
Fig. 56 Key country dynamics
Fig. 57 Spain gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Cancer incidence 2022
Fig. 59 Key country dynamics
Fig. 60 Italy gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Cancer incidence 2022
Fig. 62 Key country dynamics
Fig. 63 Denmark gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Target disease prevalence
Fig. 65 Key country dynamics
Fig. 66 Sweden gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Cancer incidence in Sweden
Fig. 68 Key country dynamics
Fig. 69 Norway gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Cancer incidence in Norway 2022
Fig. 71 Key country dynamics
Fig. 72 Switzerland gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Cancer prevalence in Switzerland 2022
Fig. 74 Key country dynamics
Fig. 75 Netherlands gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Cancer prevalence in Netherlands 2022
Fig. 77 Market participant categorization
Fig. 78 Company market share analysis, 2022
Fig. 79 Strategic framework

Companies Mentioned

  • GenScript
  • Azenta, Inc. (GENEWIZ)
  • Boster Biological Technology
  • Twist Bioscience
  • ProteoGenix, Inc
  • Biomatik.
  • ProMab Biotechnologies, Inc.
  • Thermo Fisher Scientific, Inc
  • Integrated DNA Technologies, Inc. (Danaher)
  • OriGene Technologies, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages122
PublishedAugust 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 310.6 Million
Forecasted Market Value ( USD ) by 2030 $ 998.9 Million
Compound Annual Growth Rate15.8%
Regions CoveredEurope
No. of Companies Mentioned10

Related Topics

Related Reports

Gene Synthesis (Research Use) Market Size, Share & Trends Analysis Report By Method (Solid-phase, Chip-based), By Research Phase (Pre-clinical, Clinical), By Application, By Service, By End-use, And Segment Forecasts, 2023 - 2030 - Product Image

Gene Synthesis (Research Use) Market Size, Share & Trends Analysis Report By Method (Solid-phase, Chip-based), By Research Phase (Pre-clinical, Clinical), By Application, By Service, By End-use, And Segment Forecasts, 2023 - 2030

  • Report
  • 180 Pages
  • Global
From
Global Gene Synthesis Market by Product (Hardware, Services, Software), Method (Chip-Based Synthesis, PCR-Based Enzyme Synthesis, Solid-Phase Synthesis), Gene Type, Application, End-use - Forecast 2023-2030 - Product Image

Global Gene Synthesis Market by Product (Hardware, Services, Software), Method (Chip-Based Synthesis, PCR-Based Enzyme Synthesis, Solid-Phase Synthesis), Gene Type, Application, End-use - Forecast 2023-2030

  • Report
  • 183 Pages
  • Global
From
Gene Synthesis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - Product Image

Gene Synthesis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030

  • Report
  • 220 Pages
  • Global
Global Gene Cloning Services Market by Service (Custom Cloning Service, Gene Synthesis Service, Molecular Biology Service), Application (Gene Expression, Gene Synthesis, Gene Therapy), End User - Forecast 2024-2030 - Product Image

Global Gene Cloning Services Market by Service (Custom Cloning Service, Gene Synthesis Service, Molecular Biology Service), Application (Gene Expression, Gene Synthesis, Gene Therapy), End User - Forecast 2024-2030

  • Report
  • 181 Pages
  • Global
From
Gene Synthesis Market Global Market Report 2024 - Product Image

Gene Synthesis Market Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From

About the Gene Synthesis Market

Gene Synthesis is a technology used in genomics to create custom DNA sequences. It involves synthesizing a gene from its component nucleotides, which are then assembled into a single strand of DNA. The technology is used in a variety of applications, including gene therapy, drug discovery, and agricultural biotechnology. It is also used to create custom DNA libraries for research and development. Gene Synthesis is a rapidly growing market, driven by advances in sequencing technology and the increasing demand for custom DNA sequences. The technology is used in a variety of industries, including pharmaceuticals, biotechnology, and agriculture. It is also used in academic research and in the development of new diagnostic tests. Companies in the Gene Synthesis market include GenScript, DNA2.0, Twist Bioscience, Eurofins Genomics, and Genewiz. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.